2026年5月7日 美国东部时间下午5:43 / 福克斯新闻网
法庭之友意见书声称，FDA放宽规定导致女性被胁迫服用米非司酮的案件
文/贾斯敏·贝尔 福克斯新闻
您现在可以收听福克斯新闻文章音频！
收听本文
4分钟
独家报道：福克斯新闻首发： 超过100名共和党议员敦促最高法院恢复堕胎药使用限制，警告当前允许米非司酮邮寄、无需当面审核的政策，已导致多起女性被胁迫——部分案件甚至被指被迫——服用该药物的情况。
这份由路易斯安那州联邦参议员比尔·卡西迪（R-La.）、新泽西州联邦众议员克里斯·史密斯（R-N.J.）、参议院多数党领袖约翰·图恩（R-S.D.）以及众议院议长迈克·约翰逊（R-La.）牵头提交的法庭之友意见书，支持路易斯安那州要求恢复该药物当面配药要求的法律诉讼。
此次提交的意见书核心指控是，联邦规定放宽助长了胁迫行为。议员们认为，拜登政府时期取消当面配药要求的FDA风险评估与缓解策略（REMS）修改，“增加了胁迫风险”。
意见书援引了多起堕胎药未经女性同意被获取或使用的指控案件，其中包括原告罗莎莉·马尔凯齐奇的案例。她称自己的男友从加州一名医生处订购了米非司酮，并胁迫她服用。
堕胎药米非司酮引发新一轮反堕胎争议，多名医生强调安全隐患
路易斯安那州联邦参议员比尔·卡西迪（R-La.）在国会山参议院听证会现场展示胎儿发育阶段图表。（美国参议院摄影服务机构供图）
“如果她当时当面就诊，她的男友绝不可能拿到让她服药的药物，”意见书中写道。
议员们还援引了其他多起已报道的事件，包括一起路易斯安那州母亲 allegedly 为未成年女儿在线获取堕胎药，导致医疗紧急情况的案件，以及另一起男子涉嫌在孕妇不知情的情况下给其服用堕胎药的案件。
议员们认为，在允许堕胎药在线开具、无需面对面医疗筛查即可邮寄的体系下，此类案件更有可能发生。
研究发现：每10名女性中就有1人出现“严重不良反应”的堕胎药
2024年1月24日，堕胎权支持者与反对者在华盛顿特区最高法院大楼外举行抗议活动，当日距多布斯案判决已过去三年。此次抗议恰逢德克萨斯州提交旨在阻止跨州邮寄堕胎药的标志性诉讼期间。（艾莉森·罗伯茨/《华盛顿邮报》/盖蒂图片社）
他们表示，该政策不仅削弱了安全保障，还将女性置于风险之中，并取消了旨在防止滥用的保护措施。
卡西迪表示，此类保障措施应立即恢复。
“化学堕胎药物会杀害无辜胎儿，并危及母亲的生命，”卡西迪说。“防止胁迫的保障措施，比如当面配药要求，必须立即恢复。第五巡回法院的判决是正确的，我敦促最高法院确认这一裁决。”
堕胎药争端诉诸最高法院，制造商警告裁决后将出现“混乱”
2022年6月24日，罗伊诉韦德案被推翻后，反堕胎活动人士在华盛顿特区美国最高法院外举着标语牌。（斯特凡尼·雷诺兹/法新社）
此次意见书提交之际，美国第五巡回上诉法院已支持路易斯安那州的诉求，在诉讼继续期间恢复了当面配药要求。
议员们认为，FDA允许堕胎药物通过邮寄方式流通是“越权行为”，称该政策与《康斯托克法案》冲突，该法案禁止邮寄“设计、改装或意图用于堕胎”的物品。
史密斯还援引数据称，每10名女性中就有超过1人出现感染或大出血等并发症，以此主张该药物存在严重风险。
他们还指出，FDA在取消当面配药要求时依赖了不足的安全数据，削弱了不良事件报告标准，随后又使用有限的数据为扩大配药渠道辩护。
纽约州州长霍楚签署法律保护堕胎药处方医师，此前路易斯安那州一名医生遭起诉
2024年5月23日，路易斯安那州议员通过一项法案，将两种堕胎诱导药物列为受控危险物质，尽管医生批评这些药物在其他生殖健康治疗中的用途。（艾伦·G·布里德/美联社）
意见书进一步指出，取消当面就诊环节会妨碍医生筛查包括异位妊娠在内的严重疾病，也更难发现胁迫或滥用行为。
上周末，米非司酮制造商丹科实验室和GenBioPro向最高法院提交紧急上诉，使这场法律争端进一步升级。两家公司警告称，下级法院的裁决已在全国范围内造成“直接的混乱和动荡”。
丹科实验室辩称，该裁决正在破坏药物获取渠道，迫使医疗机构、药房和患者应对快速变化的规则。而GenBioPro则表示，该命令实际上取消了邮寄配药渠道，颠覆了已沿用多年的体系。
两家公司均请求大法官们在诉讼继续期间暂停该裁决，这将引发一场可能重塑全国堕胎药分销方式的高风险法律斗争。
点击此处下载福克斯新闻APP
最高法院目前正在审议制造商提出的紧急请求，这些请求旨在在案件审理期间暂停第五巡回法院的裁决。
最终裁决可能重塑全国范围内堕胎药的获取渠道，决定它们是否继续通过邮寄广泛供应，还是再次被限制在当面医疗审核的范围内。
“这些药物确实存在将女性和女孩置于重大风险之中的合理担忧，”参议院多数党领袖图恩说。“我敦促最高法院在卫生与公众服务部审查这些药物期间，恢复拜登政府之前实施的安全保障措施。”
贾斯敏·贝尔是福克斯新闻数字频道突发新闻撰稿人，负责报道政治、军事、宗教与文化领域新闻。
FIRST ON FOX: Top Republicans take abortion pill fight to Supreme Court, citing coercion and safety risks
May 7, 2026 5:43pm EDT / Fox News
Amicus brief alleges loosened FDA rules have led to cases of women being coerced into taking mifepristone
By Jasmine Baehr Fox News
Live Action founder and president Lila Rose discusses the Supreme Court temporarily lifting restrictions on access to the abortion drug mifepristone by mail on ‘Fox News @ Night.’
NEW You can now listen to Fox News articles!
Listen to this article
4 min
FIRST ON FOX: More than 100 Republican lawmakers are urging the Supreme Court to reinstate abortion pill restrictions, warning current policy allowing mifepristone to be mailed without in-person oversight has led to cases of women being coerced — and in some instances allegedly forced — to take the drug.
The amicus brief, led by Sen. Bill Cassidy, R-La., Rep. Chris Smith, R-N.J., Senate Majority Leader John Thune, R-S.D., and House Speaker Mike Johnson, R-La., backs Louisiana’s legal fight to restore an in-person dispensing requirement for the drug.
At the center of the filing are allegations that loosened federal rules have enabled coercion, with lawmakers arguing the Biden-era policy “increases the risk of coercion,” referring to changes to the FDA’s Risk Evaluation and Mitigation Strategy (REMS) that removed the in-person requirement.
The brief points to several alleged cases in which abortion pills were obtained online or administered without a woman’s consent, including plaintiff Rosalie Markezich, who says her boyfriend ordered mifepristone from a California doctor and coerced her into taking it.
ABORTION PILL MIFEPRISTONE SPARKS NEW PRO-LIFE DEBATE AS SOME DOCTORS STRESS SAFETY CONCERNS
Sen. Bill Cassidy, R-La., speaks during a Senate hearing while pointing to a chart showing fetal development stages on Capitol Hill in Washington.(Courtesy U.S. Senate Photographic services)
“Had she visited a doctor in person, her boyfriend would never have been able to obtain the drugs he made her take,” the brief says.
Lawmakers also cite additional reported incidents, including a case in which a Louisiana mother allegedly obtained abortion pills online for her teenage daughter, leading to a medical emergency, as well as another case involving a man accused of administering the drugs to a pregnant woman without her knowledge.
Lawmakers argue such cases are more likely under a system that allows abortion pills to be prescribed online and shipped without face-to-face medical screening.
‘ABORTION PILL’ FOUND TO HAVE ‘SEVERE ADVERSE EFFECTS’ FOR 1 IN 10 WOMEN, STUDY FINDS
Activists for and against abortion demonstrate outside the Supreme Court building in Washington, D.C., on Jan. 24, 2024, three years after the Dobbs decision. The demonstration coincides with a landmark Texas filing seeking to prevent interstate abortion pill mailing.(Allison Robbert/The Washington Post/Getty Images)
They say the policy not only weakens safeguards but puts women at risk while removing protections designed to prevent abuse.
Cassidy said those safeguards should be restored immediately.
“Chemical abortion drugs kill innocent children and put mothers’ lives at risk,” Cassidy said. “Safeguards protecting against coercion, such as the in-person dispensing requirement, must be reinstated immediately. The Fifth Circuit got this right, and I urge the Supreme Court to affirm that decision.”
ABORTION PILL FIGHT HEADS TO SUPREME COURT AS MANUFACTURER WARNS OF ‘CHAOS’ AFTER RULING
Anti-abortion activists hold signs outside the U.S. Supreme Court in Washington, D.C., on June 24, 2022, following the overturning of Roe v. Wade.(Stefani Reynolds/AFP)
The filing comes after the 5th U.S. Circuit Court of Appeals sided with Louisiana and reinstated the in-person dispensing requirement while litigation continues.
Lawmakers argue the FDA “overstepped its authority” by allowing abortion drugs to be distributed through the mail, saying the policy conflicts with the Comstock Act, which prohibits mailing items “designed, adapted, or intended for producing abortion.”
Smith also argued the drug poses serious risks, citing claims that more than one in 10 women experience complications such as infection or hemorrhaging.
They also contend the agency relied on insufficient safety data when it removed the in-person requirement, weakening adverse-event reporting standards and then using limited data to justify expanded access.
NEW YORK GOV. HOCHUL SIGNS LAW PROTECTING ABORTION PILL PRESCRIBERS AFTER DOCTOR INDICTED IN LOUISIANA
Louisiana lawmakers approved a bill on May 23, 2024, classifying two abortion-inducing drugs as controlled and dangerous substances despite criticism from doctors about their other reproductive health uses.(Allen G. Breed/AP)
The brief further argues that eliminating in-person visits prevents doctors from screening for serious medical conditions, including ectopic pregnancies, and makes it more difficult to detect coercion or abuse.
The legal fight intensified over the weekend when mifepristone manufacturers Danco Laboratories and GenBioPro filed emergency appeals to the Supreme Court, warning the lower court ruling is already causing “immediate confusion and upheaval” across the country.
Danco argued the decision is disrupting access and forcing providers, pharmacies and patients to navigate rapidly changing rules, while GenBioPro said the order effectively eliminates mail-order access and upends a system relied on for years.
The companies are asking the justices to block the ruling while litigation continues, setting up a high-stakes legal battle that could reshape how the abortion drug is distributed nationwide.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The Supreme Court is now weighing emergency requests from the manufacturers, which are seeking to pause the 5th Circuit’s order while the case proceeds.
The outcome could reshape access to abortion pills nationwide, determining whether they remain widely available by mail or are once again restricted to in-person medical oversight.
“There are legitimate concerns about these drugs putting women and girls at significant risk,” said Leader Thune. “I urge the Supreme Court to reinstate the safety guardrails that were in place before the Biden administration while the Department of Health and Human Services reviews these drugs.”
Jasmine Baehr is a Breaking News Writer for Fox News Digital, where she covers politics, the military, faith and culture.
发表回复